News Briefing channel feed – Endpoints News

News Briefing channel feed

I-Mab stops work on CD73; Citius to pursue ‘strategic’ options

5 months ago

Hutchmed’s divestiture; Xgene reports Phase 2b win for non-opioid pain drug

5 months ago

Novartis ends Phase 1 radiopharma trial; Solve Therapeutics pursues $75M round

5 months ago

PDUFAs for Tonix and Nuvation; Sanofi vaccine partnership; RAPT allergy deal

5 months ago

Idorsia’s Tryvio deal delay; Galectin’s liver drug disappoints

5 months ago

Gilead deepens its stake in Assembly Biosciences; NGM licenses out MASH drug

5 months ago

Tessera gets up to $50M from the Gates Foundation; Tvardi’s reverse merger

5 months ago

Affimed’s early lung cancer data disappoint; Indapta's $22M round

5 months ago

Candid inks three T cell engager deals; PepGen trial put on hold

5 months ago

Eisai subsidiary nabs Japan rights for schizophrenia drug; Novavax's $50M milestone

5 months ago

Elevation to pay up to $368M in ADC deal; Bavarian Nordic closes San Diego site

5 months ago

BenevolentAI restructures; Cimeio, Kyowa ink cell therapy deal

5 months ago

CervoMed’s Phase 2 miss; NICE to cover Santhera’s Duchenne drug

6 months ago

Enanta's mid-stage win in pediatric RSV; Carisma to lay off 34% of staff

6 months ago

Teva to divest business venture in Japan; Layoffs at Rome Therapeutics

6 months ago

UK to limit access to Lilly’s Zepbound; VivaVision’s positive Phase 2

6 months ago

AstraZeneca's new EVP of international amid China investigation; Janux’s $300M offering

6 months ago

BMS inks deal with AI Proteins; Terns’ early-stage leukemia data

6 months ago

Senti Bio’s Phase 1 CAR-NK data; Allink raises $42M

6 months ago

Recursion reduces workforce; Oxford Nanopore teams up with UK Biobank

6 months ago

Aviceda aims to raise $200M; Nerviano gets back rights to PARP1 inhibitor

6 months ago

Replimune aims to raise $125M; Otsuka makes another deal with Ionis

6 months ago

Cidara's $100M PIPE; Pyxis Oncology's stock falls on Phase 1 data

6 months ago

Bayer, Cytokinetics make a deal in Japan; Ex-Carmot CEO to run LB Pharmaceuticals

6 months ago

First page Previous page 2 3 456 7 8 Next page Last page